Eur Rev Med Pharmacol Sci 2022; 26 (12): 4486-4496
DOI: 10.26355/eurrev_202206_29088

A narrative review of tissue-resident memory T cells and their role in immune surveillance and COVID-19

L. Chen, B. Wei, D.-L. Di

Department of Hematology, Affiliated Hospital of Weifang Medical University, Weifang, Shandong, China. 642917492@qq.com


Most effector T cells will undergo programmed apoptosis after an immune response and some of them may become memory T cells. According to the distribution and functional status, the memory T cells can be divided into effector central memory T cells (TCM), effector memory T cells (TEM) and tissue-resident memory T cells (TRM) cells. TRM cells, including CD4+ TRM and CD8+ TRM cells, colonize various barrier surfaces and are no longer involved in lymphocyte recycling, closely monitored for local perturbations in homeostasis throughout the body as a critical component of the first defense line. When pathogenic microorganisms invade the body, TRM cells can quickly produce a defense response to initiate innate immunity and adaptive immunity by producing cytokines or killer molecules to resist viral and bacterial infections. In addition, TRM cells are also involved in cancer surveillance and play an essential role in maintaining cancer-immune equilibrium. The high frequency of TRM cells in tumor tissues often means favorable survival for patients. The latest research proves that TRM cells also play an important role in vaccine development and pathological features of COVID-19. This article will summarize the biological functions of TRM cells and aims at providing references for further research on their mechanism and for targeting the best treatment of clinical disease.

Free PDF Download

To cite this article

L. Chen, B. Wei, D.-L. Di
A narrative review of tissue-resident memory T cells and their role in immune surveillance and COVID-19

Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 12
Pages: 4486-4496
DOI: 10.26355/eurrev_202206_29088